• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET Back to Search Results
Catalog Number 10220
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Dyspnea (1816); Urticaria (2278); Sweating (2444)
Event Date 10/24/2017
Event Type  Injury  
Manufacturer Narrative
Additional patient code: (b)(4).Swelling investigation is in-process.A follow-up report will be provided.
 
Event Description
The customer reported that the patient had a 'severe' reaction during a therapeutic plasma exchange (tpe) procedure.During the procedure,the patient complained of feeling diaphoretic, swelling, shortness of breath (sob) and developed hives.The rn stopped the procedure without rinse back.Per the rn, the patient was given 50mg benadryl via iv,hydrocortisone via iv, oxygen (o2) and the patient was intubated.The patient is reported in stable' condition.The patient identifier is not available at this time.The therapeutic plasma exchange (tpe) set is not available for return because it was discarded by the customer.
 
Manufacturer Narrative
The lot number was not provided, therefore, a dhr search could not be conducted for this specific incident.All lots must meet acceptance criteria for release.A terumo bct technician performed a full machine checkout at the customer site.The machine is functioning per manufacturer's specification.The technician also verified that the aim system pre and post startup tests successfully passed.An auto test and saline run were also successfully performed.Investigation is in process.A follow-up report will be provided.
 
Event Description
The customer did not respond to attempts to obtain information for the investigation such as procedural details, patient information and lot information.
 
Manufacturer Narrative
According to therapeutic apheresis: a physician's handbook, adverse events occur during therapeutic procedures with a frequency of 4.8%.Symptoms of these allergic reactions may include hives, dyspnea, wheezing, burning eyes, tachycardia, hypotension, and or facial swelling and flushing.Mild reactions can be treated with diphenhydramine administered through an iv.The run data file (rdf) was analyzed for this event.The signals in the rdf indicated that the spectra optia system operated as intended.Root cause: a definitive root cause for the patient's reaction could not be determined.Based on customer's statements about the allergic reaction and the literature review, possible causes for the patient's reaction include but are not limited to an allergy to replacement solution and/or patient sensitivity to eto.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA
Type of Device
SPECTRA OPTIA EXCHANGE SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer Contact
steve kern
10810 w.collins ave
lakewood, CO 80215
3032392246
MDR Report Key7040868
MDR Text Key92318298
Report Number1722028-2017-00446
Device Sequence Number1
Product Code LKN
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K153601
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Health Professional
Type of Report Initial,Followup,Followup
Report Date 11/17/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number10220
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/24/2017
Initial Date FDA Received11/17/2017
Supplement Dates Manufacturer Received12/11/2017
02/13/2018
Supplement Dates FDA Received12/12/2017
02/23/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age00025 YR
Patient Weight95
-
-